McKesson Corporation Closed Now

McKesson Corporation, founded in New York City in 1833 and now headquartered in Irving, Texas, is one of the largest healthcare companies globally, specializing in pharmaceutical distribution, medical technologies, and health information systems. The company distributes roughly one‑third of all pharmaceutical products used in North America and provides solutions to hospitals, pharmacies, biotech firms, and governments Wikipedia.

In fiscal year ending March 31, 2025, McKesson generated $359.05 billion in revenue—a 16.2% increase over fiscal 2024—boosted by strong growth in its U.S. Pharmaceutical unit and demand for specialty drugs like oncology and GLP‑1 therapies Reuters+4Distribution Strategy Group+4mckesson.com+4. Full‑year net income reached $3.295 billion, up nearly 10% from the prior year despite operating under thin margins typical of its industry Macrotrends.

The company is currently restructuring to improve strategic focus and shareholder value, announcing its intention to spin off the Medical‑Surgical Solutions segment into an independent entity. This will enable McKesson to prioritize higher-margin areas like oncology and biopharma distribution, while the new company drives growth in medical‑surgical supply markets mckesson.com.

While McKesson’s profit margins remain tight—about 1%—its resilience stems from scale, steady demand, and industry leadership. As of mid‑2025, analysts and investors view McKesson as a defensive, reliable stock, benefiting from growing medication demand, especially among aging populations and GLP‑1 drug users Barron’s. Its stock’s Relative Strength Rating has climbed to over 80, signaling strong market momentum in its sector Investors+2Investors+2Investors+2.

Looking ahead, McKesson plans to double down on specialty pharma logistics, streamline operations, invest in margin‑rich segments, and complete its portfolio restructuring. The company’s scale, distribution network, and strategic clarity position it for sustained growth in global healthcare supply chains.